These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9322677)

  • 1. Inhibitors to clotting factors.
    Sallah S
    Ann Hematol; 1997; 75(1-2):1-7. PubMed ID: 9322677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired inhibitors of coagulation factors: part II.
    Franchini M; Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2012 Jul; 38(5):447-53. PubMed ID: 22740184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of factor VIII inhibitors.
    Kasper CK
    Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous inhibitors to coagulation factors.
    Green D
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():21-5; discussion 30-2. PubMed ID: 11251655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating anticoagulants. Clinical conditions of diagnosis].
    Godeau P; Blétry O; Piette JC; Wechsler B
    Rev Med Interne; 1985 Dec; 6(5):523-41. PubMed ID: 3938557
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction in hemophilia: innovation and accomplishments.
    Sherman A; Biswas M; Herzog RW
    Curr Opin Hematol; 2018 Sep; 25(5):365-372. PubMed ID: 29994897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired circulating anticoagulants.
    Kunkel LA
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1341-57. PubMed ID: 1452516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.
    Livnat T; Zivelin A; Tamarin I; Guetta V; Salomon O
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):661-6. PubMed ID: 19730246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis and classification of autoimmune coagulopathy: an updated review.
    Chang HH; Chiang BL
    Autoimmun Rev; 2014; 13(4-5):587-90. PubMed ID: 24424199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.
    Coppola A; Favaloro EJ; Tufano A; Di Minno MN; Cerbone AM; Franchini M
    Semin Thromb Hemost; 2012 Jul; 38(5):433-46. PubMed ID: 22740182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of antiphospholipid antibodies.
    Martini A; Ravelli A
    Ann Med; 1997 Apr; 29(2):159-63. PubMed ID: 9187233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory, clinical and therapeutic aspects of acquired hemophilia A.
    Franchini M; Targher G; Montagnana M; Lippi G
    Clin Chim Acta; 2008 Sep; 395(1-2):14-8. PubMed ID: 18505682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired factor VIII inhibitors in oncohematology: a systematic review.
    Franchini M; Targher G; Manzato F; Lippi G
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):194-9. PubMed ID: 18243727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options.
    Feldmann E; Levine SR
    Ann Neurol; 1995 May; 37 Suppl 1():S114-30. PubMed ID: 8968222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.